Gary E. Lemack MDProfessor of Urology and Neurology, Rose Mary Haggar Professor of Urology, Residency Program Director in Urology, University of Texas Southwestern Medical Center, Dallas, Texas
Dr. Gary Lemack is Professor of Urology and Neurology in the Department of Urology at the University of Texas Southwestern Medical Center in Dallas, where he is also Director of Neurourology. He is the fellowship director for female pelvic medicine and reconstructive surgery and has been the residency program director in the Department of Urology since 2004.
His clinical specialties include incontinence, pelvic organ prolapse, and voiding dysfunction in the setting of neurologic disease. The focus of his clinical research is on the use of urodynamic studies in patients with lower urinary tract dysfunction/incontinence and on establishing best urological practices in the care of patients with multiple sclerosis and other neurological conditions.
Dr. Lemack earned his medical degree from Cornell University and performed his residency at New York Hospital. His fellowship training at UT Southwestern focused on incontinence, urodynamics, and neurourology.
Recent Contributions to PracticeUpdate:
- Methods to Identify Stress Urinary Incontinence in Women With Pelvic Organ Prolapse
- Use of Botulinum Toxin A in Detrusor External Sphincter Dyssynergia
- National Trends in the Surgical Management of Urinary Incontinence Among Women
- Lower Urinary Tract Symptoms in Adults Due to Rare Inherited Neuromuscular Diseases
- Vaginal Pessary Used to Decide Whether a Midurethral Sling Should Be Added to Prolapse Surgery
- Real World Performance of SNM and OnabotulinumtoxinA for Overactive Bladder
- Prediction Model for Stress Urinary Incontinence After Vaginal Prolapse Repair
- Augmentation Cystoplasty and Botulinum Toxin Injection for Individuals With Spinal Cord Injury Performing Clean Intermittent Catheterization
- Long-Term Rate of Mesh Sling Removal Following Midurethral Mesh Sling Insertion
- Assessment of Renal Deterioration and Associated Risk Factors in Patients With Multiple Sclerosis